Physician

Benjamin Steven Crouch, D.O.

According to 2025 Medicare claims, Benjamin Crouch, D.O. (NPI: 1336302546) practices physical medicine and rehabilitation in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is REVERE HEALTH PC (NPI: 1093764805; TIN: 870281028) and primary practice location at 84653-9998. Crouch is affiliated with the Revere Health Collaborative Network, LLC (ACO ID: D0042), participating under the REACH model.

Crouch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 10,816 HCPCS/CPT codes, and received $258,320 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 1,443 prescription claims across 191 beneficiaries totaling $78,487 in drug costs, led by Buprenorphine (Buprenorphine). Open Payments data shows 22 records totaling $682. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $46,599 and ending at $78,487. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	333	2,907	$186,815
2016	370	4,903	$188,331
2017	411	6,638	$237,326
2018	432	6,868	$244,743
2019	530	7,249	$329,663
2020	400	6,290	$246,287
2021	412	6,392	$273,400
2022	387	6,013	$244,610
2023	370	5,946	$238,048
2024	338	10,816	$258,320

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	82	384	$46,599
2016	100	588	$54,587
2017	115	817	$81,026
2018	92	797	$91,230
2019	96	716	$75,432
2020	105	844	$45,156
2021	140	992	$52,588
2022	139	1,024	$60,572
2023	171	1,196	$64,299
2024	191	1,443	$78,487

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	83	131	$168
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	246	810	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	118	155	$61
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	181	430	$12
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	209	2,601	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Buprenorphine	Buprenorphine	15	938	$11,619
Belbuca	Buprenorphine Hcl	12	360	$9,727
Xtampza Er	Oxycodone Myristate	13	370	$8,951
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	233	6,177	$8,555
Movantik	Naloxegol Oxalate	14	420	$5,679

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$682	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Benjamin Steven Crouch, D.O.?

Tedicare shows public-source Medicare data for Benjamin Steven Crouch, D.O. (NPI 1336302546), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Steven Crouch, D.O. have ACO affiliation data?

Benjamin Steven Crouch, D.O. is shown with ACO affiliation data for Revere Health Collaborative Network, LLC (REACH, ACO ID D0042).

What billing organization is linked to Benjamin Steven Crouch, D.O.?

Benjamin Steven Crouch, D.O. is linked to REVERE HEALTH PC (billing NPI 1093764805) in the available physician profile data.

Does Benjamin Steven Crouch, D.O. have Open Payments data?

Benjamin Steven Crouch, D.O. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.